The themes Envista is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Udziały w przychodach to szacunki za six months ended July 3, 2026, a nie dane z raportu złożonego do regulatora.
Dental implant systems and related products
Systems for replacing missing teeth, including implants, guided-surgery products, bone-regeneration materials, and tooth restorations. Brands include Nobel Biocare, Alpha-Bio Tec, and Implant Direct.
DTX Studio software
Software that helps dental professionals review patient images and plan implant procedures and restorations.
Orthodontic brackets, wires, and related products
Products orthodontists use to move teeth, including brackets, wires, tubes, bands, retainers, and laboratory products. Brands include Ormco and Damon.
Spark clear aligners
Removable clear trays used to straighten teeth, with software for planning and reviewing treatment.
Dental imaging equipment
Dental X-ray systems, digital sensors, and intraoral scanners used to capture images of patients’ teeth and mouths. Brands include DEXIS and i-CAT.
Dental consumables and infection-prevention products
Materials and tools used in routine dental care, including restorative materials, root-canal products, burs, bonding agents, cements, and surface disinfectants. Brands include Kerr, Sybron Endo, and Metrex.
Pełne sprawozdania finansowe →
Envista makes products used to diagnose, treat, and prevent problems with teeth and gums, and to improve smiles. It sells to general dentists, dental specialists, orthodontists, dental laboratories, and dental groups, directly and through distributors. Its products range from dental imaging and treatment-planning software to tooth-replacement systems, braces, restorative materials, root-canal products, and disinfectants.
Zbudowane z własnych raportów spółki Envista Holdings Corporation składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
NVST · NYSE · Healthcare · Medical Instruments and Supplies
24,66 USD-2,5%zamknięcie 12 lis
Dane do 2 października 2026, z raportu 10-Q złożonego 4 listopada 2026
Envista makes dental implants, orthodontic braces and clear aligners, dental imaging equipment and software, and materials used in dental care.
Just reported
From Envista's results release of 4 listopada 2026; its quarterly report has since been filed.
Actual
691,5M USD
+3,2% y/y
-5,3% q/q
Guided
—
No guide given
Actual
3,11 USD
Guided
—
No guide given
EPS, adjusted: 0,40 USD
Actual
515,2M USD
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Grade B+
Pasek pod ceną pokazuje ocenę w każdym dniu, wyliczoną wyłącznie z dokumentów, które były wtedy już publiczne.
Pokazujemy 2 z 28 kwartałów historii ocen spółki Envista Holdings Corporation. Pozostałe 26 sięgają do luty 2020.